The effect of thioredoxin on the expression of proopiomelanocortin-derived peptides, the melanocortin 1 receptor and cell survival of normal human keratinocytes.

An important constituent of the cellular antioxidant buffering system that controls the redox state of proteins is thioredoxin (TRX), a 13 kDa protein that catalyzes thiol-disulfide exchange reactions, regulates activation of transcription factors, and possesses several other biologic functions similar to cytokines. We have previously reported that TRX released from UVB-irradiated keratinocytes stimulates melanogenesis by upregulating MSH receptor expression and its binding activity in melanocytes. The purpose of this study was to examine the effects of TRX on keratinocytes as an autocrine factor. TRX suppressed the UVB-induced production and secretion of alpha-melanocyte stimulating hormone (alpha-MSH) and of adrenocorticotropic hormone (ACTH), and also suppressed proopiomelanocortin (POMC) mRNA expression by normal human keratinocytes; however, TRX upregulated melanocortin 1 receptor (MC1-R) expression synergistically with UVB in normal human keratinocytes. These results suggest that exogenous TRX regulates expression of those genes in different manners. Furthermore, addition of an antibody against TRX induced cell death in keratinocytes, probably due to enhanced signaling of MSH, as it has been shown that MSH suppresses heat shock protein (hsp) 70 expression in differentiated keratinocytes, which express high levels of MC1-R and decreases their survival rate during oxidative stress. Taken together, the results suggest that keratinocyte-derived TRX regulates the expression of stress inducible neuropeptides and their receptor, and is critically involved in the survival of keratinocytes.

[1]  K. Mori,et al.  Distinct Roles of Thioredoxin in the Cytoplasm and in the Nucleus , 1999, The Journal of Biological Chemistry.

[2]  G. Chrousos,et al.  Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. , 1999, The journal of investigative dermatology. Symposium proceedings.

[3]  A. Chakraborty,et al.  Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. , 1999, The Journal of investigative dermatology.

[4]  K. Nozaki,et al.  Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Inoue,et al.  Modulation of melanocyte‐stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin‐1α, interleukin‐1β, endothelin‐1 and tumour necrosis factor‐α , 1998 .

[6]  D. Slater,et al.  Changes in the expression of the type‐2 but not the type‐1 cyclo‐oxygenase enzyme in chorion‐decidua with the onset of labour , 1998, British journal of obstetrics and gynaecology.

[7]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[8]  J. Mazurkiewicz,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society COMMENTS Characterization of Corticotropin-Releasing Hormone , 2022 .

[9]  C. White,et al.  Elevation of Manganese Superoxide Dismutase Gene Expression by Thioredoxin , 1995 .

[10]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Luger,et al.  Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. , 1997, Journal of immunology.

[12]  J. Yodoi,et al.  Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. , 1997, Journal of immunology.

[13]  F. Trautinger,et al.  alpha-Melanocyte stimulating hormone downregulates differentiation-driven heat shock protein 70 expression in keratinocytes. , 1997, The Journal of investigative dermatology.

[14]  M. Ichihashi,et al.  The effect of ultraviolet B induced adult T cell leukemia-derived factor/thioredoxin (ADF/TRX) on survival and growth of human melanocytes. , 1997, Pigment cell research.

[15]  A. Chakraborty,et al.  Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. , 1996, Biochimica et biophysica acta.

[16]  J. Yodoi,et al.  Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. , 1996, The Journal of clinical investigation.

[17]  M. Mihm,et al.  Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin , 1995, FEBS letters.

[18]  A. Holmgren,et al.  Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. , 1995, Structure.

[19]  H. Masutani,et al.  Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. , 1995, Immunology letters.

[20]  Y. Yamaoka,et al.  Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.

[21]  F. Trautinger,et al.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. , 1994, The Journal of clinical investigation.

[22]  K. Schulze-Osthoff,et al.  Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Masutani,et al.  Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[24]  R. Paus,et al.  On the potential role of proopiomelanocortin in skin physiology and pathology , 1993, Molecular and Cellular Endocrinology.

[25]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[26]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[27]  M. Karin,et al.  The mammalian ultraviolet response is triggered by activation of src tyrosine kinases , 1992, Cell.

[28]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[29]  J. Yodoi,et al.  Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. , 1992, Biochemical and biophysical research communications.

[30]  J. Yodoi,et al.  Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. , 1992, International immunology.

[31]  D. Williams,et al.  c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. , 1992, Molecular biology of the cell.

[32]  H. Nakamura,et al.  Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. , 1991, Journal of immunology.

[33]  R. Paus,et al.  Can some melanotropins modulate keratinocyte proliferation? , 1991, The Journal of investigative dermatology.

[34]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[35]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[36]  K. Schulze-Osthoff,et al.  転写因子NF‐κBとAP‐1の活性化に及ぼすチオレドキシンと抗酸化剤の異なった効果 , 1994 .

[37]  J. Yodoi,et al.  Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. , 1992, Immunology today.

[38]  J. Wood,et al.  Free radical reduction in the human epidermis. , 1989, Free radical biology & medicine.